Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 476 shares, the number of shares held decreased 1.71% compared to the previous period and now represents 1.08% of the total position.
ARKG Investment Tracker position change: Decreased position in Veracyte by 25,976 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 5.17% of the total position.
ARKG Investment Tracker position change: Decreased position in Natera by 6,239 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 5.14% of the total position.
ARKG Investment Tracker position change: Decreased position in Regeneron Pharmaceuticals by 238 shares, the number of shares held decreased 1.65% compared to the previous period and now represents 0.93% of the total position.
ARKG Investment Tracker position change: Decreased position in Veeva by 1,581 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 1.68% of the total position.
ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 50,014 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 3.45% of the total position.
ARKG Investment Tracker position change: Decreased position in Illumina by 1,870 shares, the number of shares held decreased 1.71% compared to the previous period and now represents 1.28% of the total position.
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 22,457 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 3.85% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 215,645 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 6.87% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 41,361 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 3.98% of the total position.
ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 40,766 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 8.55% of the total position.
ARKG Investment Tracker position change: Decreased position in Incyte by 3,026 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 1.08% of the total position.
ARKG Investment Tracker position change: Decreased position in Moderna, Inc. by 17 shares, the number of shares held decreased 4.31% compared to the previous period and now represents 0.0012% of the total position.
ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 32,453 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 4.17% of the total position.
ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 26,962 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 4.2% of the total position.
ARKG Investment Tracker position change: Decreased position in Exact Sciences by 1,785 shares, the number of shares held decreased 1.72% compared to the previous period and now represents 0.49% of the total position.
ARKG Investment Tracker position change: Increased position in Intellia Therapeutics by 7,581 shares, the number of shares held increased 0.25% compared to the previous period and now represents 3.78% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 159,670 shares, the number of shares held decreased 1.26% compared to the previous period and now represents 1.9% of the total position.
ARKG Investment Tracker position change: Decreased position in CRISPR Therapeutics AG by 30,776 shares, the number of shares held decreased 1.58% compared to the previous period and now represents 7.92% of the total position.
ARKG Investment Tracker position change: Decreased position in Amgen by 1,241 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 1.77% of the total position.
I closed $Royal Caribbean Cruises(RCL)$ ,I closed $Royal Caribbean Cruises(RCL)$ , Sold took profit Royal Caribbean Cruises (RCL) - A Trader's Perspective Strengths: Strong Brand Recognition: RCL is a globally recognized and trusted brand in the cruise industry. This translates to consistent demand and customer loyalty. Diversified Fleet and Destinations: RCL offers a vast array of cruise experiences, catering to different budgets and interests. This diversity helps attract a broader customer base. Growth Opportunities: The cruise industry continues to expand, with new destinations and ships being introduced regularly. RCL is well-positioned to capitalize on this growth. Cost Management: T
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 159,670 shares, the number of shares held decreased 1.26% compared to the previous period and now represents 1.9% of the total position.
ARKK Investment Tracker position change: Increased position in Pacific Biosciences of California by 491,480 shares, the number of shares held increased 2.42% compared to the previous period and now represents 0.55% of the total position.
ARKK Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 368,100 shares, the number of shares held increased 1.97% compared to the previous period and now represents 1.84% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 215,645 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 6.87% of the total position.
ARKG Investment Tracker position change: Decreased position in Regeneron Pharmaceuticals by 238 shares, the number of shares held decreased 1.65% compared to the previous period and now represents 0.93% of the total position.
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 476 shares, the number of shares held decreased 1.71% compared to the previous period and now represents 1.08% of the total position.
ARKK Investment Tracker position change: Increased position in Palantir Technologies Inc. by 106,425 shares, the number of shares held increased 1.97% compared to the previous period and now represents 5.35% of the total position.
ARKG Investment Tracker position change: Decreased position in Veracyte by 25,976 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 5.17% of the total position.
ARKK Investment Tracker position change: Increased position in Tesla Motors by 11,595 shares, the number of shares held increased 0.41% compared to the previous period and now represents 15.25% of the total position.
ARKK Investment Tracker position change: Increased position in SoFi Technologies Inc. by 111,420 shares, the number of shares held increased 1.97% compared to the previous period and now represents 1.28% of the total position.
ARKK Investment Tracker position change: Increased position in Intellia Therapeutics by 330,113 shares, the number of shares held increased 3.93% compared to the previous period and now represents 1.91% of the total position.
ARKG Investment Tracker position change: Decreased position in Natera by 6,239 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 5.14% of the total position.
ARKG Investment Tracker position change: Decreased position in Veeva by 1,581 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 1.68% of the total position.
ARKK Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 93,195 shares, the number of shares held increased 1.97% compared to the previous period and now represents 1.88% of the total position.
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 22,457 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 3.85% of the total position.
ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 50,014 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 3.45% of the total position.
ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 32,453 shares, the number of shares held decreased 1.7% compared to the previous period and now represents 4.17% of the total position.
ARKG Investment Tracker position change: Decreased position in CRISPR Therapeutics AG by 30,776 shares, the number of shares held decreased 1.58% compared to the previous period and now represents 7.92% of the total position.
ARKK Investment Tracker position change: Increased position in Advanced Micro Devices by 10,215 shares, the number of shares held increased 1.97% compared to the previous period and now represents 1.14% of the total position.